NOXX Therapeutics, Inc.

CIK 1996801 · operating company. SEC filings, financial statements, 10-K sections, 8-K items and insider trades for NOXX Therapeutics, Inc..

Recent SEC filings

FiledFormAccession number
Mar 31, 2026D0001999371-26-007308
Oct 11, 2023D0001387131-23-012110